These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Characterization of NK1 and NK2 tachykinin receptors in guinea-pig and rat bronchopulmonary and vascular systems. Floch A, Fardin V, Cavero I. Br J Pharmacol; 1994 Mar; 111(3):759-68. PubMed ID: 7517328 [Abstract] [Full Text] [Related]
7. Differences in the distribution and characteristics of tachykinin NK1 binding sites between human and guinea pig lung. Walsh DA, Salmon M, Featherstone R, Wharton J, Church MK, Polak JM. Br J Pharmacol; 1994 Dec; 113(4):1407-15. PubMed ID: 7534186 [Abstract] [Full Text] [Related]
8. Effects of an NK1 receptor antagonist, FK888, on constriction and plasma extravasation induced in guinea pig airway by neurokinins and capsaicin. Murai M, Maeda Y, Hagiwara D, Miyake H, Ikari N, Matsuo M, Fujii T. Eur J Pharmacol; 1993 May 12; 236(1):7-13. PubMed ID: 7686493 [Abstract] [Full Text] [Related]
9. Pharmacological analysis of [3H]-senktide binding to NK3 tachykinin receptors in guinea-pig ileum longitudinal muscle-myenteric plexus and cerebral cortex membranes. Guard S, Watson SP, Maggio JE, Too HP, Watling KJ. Br J Pharmacol; 1990 Apr 12; 99(4):767-73. PubMed ID: 1694464 [Abstract] [Full Text] [Related]
10. Subtype- and species-selectivity of a tachykinin receptor antagonist, FK888, for cloned rat and human tachykinin receptors. Aramori I, Morikawa N, Zenkoh J, O'Donnell N, Iwami M, Kojo H, Notsu Y, Okuhara M, Ono S, Nakanishi S. Eur J Pharmacol; 1994 Oct 14; 269(2):277-81. PubMed ID: 7531648 [Abstract] [Full Text] [Related]
11. Comparative, general pharmacology of SDZ NKT 343, a novel, selective NK1 receptor antagonist. Walpole CS, Brown MC, James IF, Campbell EA, McIntyre P, Docherty R, Ko S, Hedley L, Ewan S, Buchheit KH, Urban LA. Br J Pharmacol; 1998 May 14; 124(1):83-92. PubMed ID: 9630347 [Abstract] [Full Text] [Related]
12. Pharmacological properties of a potent and selective nonpeptide substance P antagonist. Garret C, Carruette A, Fardin V, Moussaoui S, Peyronel JF, Blanchard JC, Laduron PM. Proc Natl Acad Sci U S A; 1991 Nov 15; 88(22):10208-12. PubMed ID: 1719549 [Abstract] [Full Text] [Related]
18. Pharmacology of the peptidomimetic, MEN 11149, a new potent, selective and orally effective tachykinin NK1 receptor antagonist. Cirillo R, Astolfi M, Conte B, Lopez G, Parlani M, Terracciano R, Fincham CI, Manzini S. Eur J Pharmacol; 1998 Jan 12; 341(2-3):201-9. PubMed ID: 9543241 [Abstract] [Full Text] [Related]
19. A pharmacological study of NK1 and NK2 tachykinin receptor characteristics in the rat isolated urinary bladder. Hall JM, Flowers JM, Morton IK. Br J Pharmacol; 1992 Nov 12; 107(3):777-84. PubMed ID: 1282072 [Abstract] [Full Text] [Related]
20. Activity of peptide and non-peptide antagonists at peripheral NK1 receptors. Patacchini R, Santicioli P, Astolfi M, Rovero P, Viti G, Maggi CA. Eur J Pharmacol; 1992 Apr 29; 215(1):93-8. PubMed ID: 1381319 [Abstract] [Full Text] [Related] Page: [Next] [New Search]